Novo Holdings’ investment alongside Biocomposites’ existing shareholder, TA Associates, will help the company scale its pipeline.

Biocomposites is headquartered in Keele, UK TA has been Biocomposites’ majority shareholder since 2017 Novo Holdings and TA Associates have agreed to make an investment into Biocomposites.

Since partnering with TA in 2017, Biocomposites has achieved significant growth – including a threefold increase in revenues, successful geographic expansion, and continued product diversification.

Novo Holdings’ investment alongside Biocomposites’ existing shareholder, TA Associates, will help the company scale its pipeline.

“TA has been a fantastic long-term partner to us, and we are excited for the future alongside them and Novo Holdings,” said Michael Harris, Biocomposites’ CEO. “This investment is a significant ...

As part of the transaction TA, Biocomposites' majority shareholder since 2017, will reinvest in the Company alongside new investor Novo Holdings and Biocomposites' management.

Novo Holdings and TA Associates ("TA"), announced today that the parties have entered into an agreement for Novo Holdings to make an investment in Biocomposites ("the Company"), an international ...